Recombinant human histone H1.3

N/A

Report date: 2022/03/17 10:56:22

Base Information

Drug NameRecombinant human histone H1.3
Drug Alias NamerhH1.3OncoHistProduct FSYN-20051504RUSYN-20051604RU
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCell membrane modulatorsApoptosis stimulantsNucleosome binders
TargetsNucleosome
Therapy Area/IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSymbio Llc
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteSymbio LlcPharmsynthez +[4] 
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A